Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

HIV and lower risk of multiple sclerosis: beginning to unravel a mystery using a record-linked database study.
Paraneoplastic neuromyelitis optica associated with ANNA-1 antibodies in invasive thymoma.
Multiple sclerosis in the mount etna region: possible role of volcanogenic trace elements.
[Biomarkers in multiple sclerosis (a review and experimental data)].
Comparison of Sleep Problems in Individuals with Spinal Cord Injury and Multiple Sclerosis.
Beneficial Effect of Tolerogenic Dendritic Cells Pulsed with MOG Autoantigen in Experimental Autoimmune Encephalomyelitis.
EP2 Receptor Signaling Regulates Microglia Death.
Longitudinal monitoring of metabolic alterations in cuprizone mouse model of multiple sclerosis using 1H-magnetic resonance spectroscopy.
Linking synaptopathy and gray matter damage in multiple sclerosis.
An introduction to the roles of purinergic signalling in neurodegeneration, neuroprotection and neuroregeneration.
Murine K2P5.1 Deficiency Has No Impact on Autoimmune Neuroinflammation due to Compensatory K2P3.1- and KV1.3-Dependent Mechanisms.
The unfolded protein response in multiple sclerosis.
A case of neuromyelitis optica spectrum disorder presenting with severe orthostatic hypotension.
Oxidised LDL lipids, statins and a blood-brain barrier.
Identifying the biomarkers of multiple sclerosis based on non-coding RNA signature.
Children of chronically ill parents: Relationship between parental multiple sclerosis and childhood developmental health.
Hypomorphic MGAT5 polymorphisms promote multiple sclerosis cooperatively with MGAT1 and interleukin-2 and 7 receptor variants.
Effects of pregnancy and breastfeeding on the multiple sclerosis disease course.
Circulating levels of soluble apoptosis-related molecules in patients with multiple sclerosis.
A novel nanoparticle containing MOG peptide with BTLA induces T cell tolerance and prevents multiple sclerosis.
Visual Evoked Potential and Magnetic Resonance Imaging are More Effective Markers of Multiple Sclerosis Progression than Laser Polarimetry with Variable Corneal Compensation.
Regulation: The FDA is overcautious on consumer genomics.
Discovery of Clinical Candidate GSK1842799 As a Selective S1P1 Receptor Agonist (Prodrug) for Multiple Sclerosis.
B-59Comprehensive Examination of Factors Contributing to Employment Status in Multiple Sclerosis.
Activities of the European multiple sclerosis platform.

Pages